Skip to main content
Erschienen in: Journal of Neuro-Oncology 3/2013

01.09.2013 | Clinical Study

The fate of spinal schwannomas following subtotal resection: a retrospective multicenter study by the Korea spinal oncology research group

verfasst von: Seil Sohn, Chun Kee Chung, Sung-Hye Park, Eun-Sang Kim, Ki-Jeong Kim, Chi Heon Kim

Erschienen in: Journal of Neuro-Oncology | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

The fate of residual spinal schwannomas needs to be estimated in order to plan further management after subtotal removal. Our aim was to evaluate the growth rate of residual spinal schwannomas and compare results in regrowth and no regrowth groups by using data collected from the Korea Spinal Oncology Research Group database. From January 1989 to August 2011, 27 patients with residual spinal schwannomas were selected. Patients with at least two follow-up magnetic resonance image (MRI) studies after subtotal resection were included. The mean period of MRI follow-up was 62.4 months. A tumor size increase of over 2 mm in the maximal diameter was considered indicative of regrowth. Age, sex, size at initial diagnosis, postoperative tumor size, and Ki-67 labeling index were compared between regrowth and no regrowth groups. Eight residual schwannomas regrew (29.6 %), and 19 (70.4 %) did not regrow. Average growth rate of the regrowing tumors was 1.0 ± 4.4 mm/year. The mean percentage increase in tumor size during follow-up was 10.0 ± 28.8 %. The Ki-67 labeling indices were significantly different between regrowth and no regrowth groups (P = 0.014). Two patients underwent a revision operation for significant tumor regrowth. Nineteen cases (70.4 %) among 27 residual spinal schwannomas did not regrow significantly, but further surgical treatments were necessary in 2 patients due to significant regrowth. The Ki-67 labeling index was higher in the regrowth group. Earlier follow-up MRI is recommended for patients whose tumors have higher Ki-67.
Literatur
1.
Zurück zum Zitat Celli P, Trillo G, Ferrante L (2005) Spinal extradural schwannoma. J Neurosurg Spine 2(4):447–456PubMedCrossRef Celli P, Trillo G, Ferrante L (2005) Spinal extradural schwannoma. J Neurosurg Spine 2(4):447–456PubMedCrossRef
2.
Zurück zum Zitat Seppala MT, Haltia MJ, Sankila RJ, Jaaskelainen JE, Heiskanen O (1995) Long-term outcome after removal of spinal schwannoma: a clinicopathological study of 187 cases. J Neurosurg 83(4):621–626PubMedCrossRef Seppala MT, Haltia MJ, Sankila RJ, Jaaskelainen JE, Heiskanen O (1995) Long-term outcome after removal of spinal schwannoma: a clinicopathological study of 187 cases. J Neurosurg 83(4):621–626PubMedCrossRef
3.
Zurück zum Zitat Conti P, Pansini G, Mouchaty H, Capuano C, Conti R (2004) Spinal neurinomas: retrospective analysis and long-term outcome of 179 consecutively operated cases and review of the literature. Surg Neurol 61(1):34–43; discussion 44 Conti P, Pansini G, Mouchaty H, Capuano C, Conti R (2004) Spinal neurinomas: retrospective analysis and long-term outcome of 179 consecutively operated cases and review of the literature. Surg Neurol 61(1):34–43; discussion 44
4.
Zurück zum Zitat Safavi-Abbasi S, Senoglu M, Theodore N et al (2008) Microsurgical management of spinal schwannomas: evaluation of 128 cases. J Neurosurg Spine 9(1):40–47PubMedCrossRef Safavi-Abbasi S, Senoglu M, Theodore N et al (2008) Microsurgical management of spinal schwannomas: evaluation of 128 cases. J Neurosurg Spine 9(1):40–47PubMedCrossRef
5.
Zurück zum Zitat Ozawa H, Onoda Y, Aizawa T, Nakamura T, Koakutsu T, Itoi E (2012) Natural history of intradural-extramedullary spinal cord tumors. Acta Neurol Belg 112(3):265–270PubMedCrossRef Ozawa H, Onoda Y, Aizawa T, Nakamura T, Koakutsu T, Itoi E (2012) Natural history of intradural-extramedullary spinal cord tumors. Acta Neurol Belg 112(3):265–270PubMedCrossRef
6.
Zurück zum Zitat Fukuda M, Oishi M, Hiraishi T, Natsumeda M, Fujii Y (2011) Clinicopathological factors related to regrowth of vestibular schwannoma after incomplete resection. J Neurosurg 114(5):1224–1231PubMed Fukuda M, Oishi M, Hiraishi T, Natsumeda M, Fujii Y (2011) Clinicopathological factors related to regrowth of vestibular schwannoma after incomplete resection. J Neurosurg 114(5):1224–1231PubMed
7.
Zurück zum Zitat Linthicum FH Jr, Saleh ES, Hitselberger WE, Brackmann DE, Hung G (2002) Growth of postoperative remnants of unilateral vestibular nerve schwannoma: role of the vestibular ganglion. ORL J Otorhinolaryngol Relat Spec 64(2):138–142PubMedCrossRef Linthicum FH Jr, Saleh ES, Hitselberger WE, Brackmann DE, Hung G (2002) Growth of postoperative remnants of unilateral vestibular nerve schwannoma: role of the vestibular ganglion. ORL J Otorhinolaryngol Relat Spec 64(2):138–142PubMedCrossRef
8.
Zurück zum Zitat Ohta S, Yokoyama T, Nishizawa S, Uemura K (1998) Regrowth of the residual tumour after acoustic neurinoma surgery. Br J Neurosurg 12(5):419–422PubMedCrossRef Ohta S, Yokoyama T, Nishizawa S, Uemura K (1998) Regrowth of the residual tumour after acoustic neurinoma surgery. Br J Neurosurg 12(5):419–422PubMedCrossRef
9.
Zurück zum Zitat El-Kashlan HK, Zeitoun H, Arts HA, Hoff JT, Telian SA (2000) Recurrence of acoustic neuroma after incomplete resection. Am J Otol 21(3):389–392PubMedCrossRef El-Kashlan HK, Zeitoun H, Arts HA, Hoff JT, Telian SA (2000) Recurrence of acoustic neuroma after incomplete resection. Am J Otol 21(3):389–392PubMedCrossRef
10.
Zurück zum Zitat Cerullo L, Grutsch J, Osterdock R (1998) Recurrence of vestibular (acoustic) schwannomas in surgical patients where preservation of facial and cochlear nerve is the priority. Br J Neurosurg 12(6):547–552PubMedCrossRef Cerullo L, Grutsch J, Osterdock R (1998) Recurrence of vestibular (acoustic) schwannomas in surgical patients where preservation of facial and cochlear nerve is the priority. Br J Neurosurg 12(6):547–552PubMedCrossRef
11.
Zurück zum Zitat Kameyama S, Tanaka R, Honda Y, Hasegawa A, Yamazaki H, Kawaguchi T (1994) The long-term growth rate of residual acoustic neurinomas. Acta Neurochir (Wien) 129(3–4):127–130CrossRef Kameyama S, Tanaka R, Honda Y, Hasegawa A, Yamazaki H, Kawaguchi T (1994) The long-term growth rate of residual acoustic neurinomas. Acta Neurochir (Wien) 129(3–4):127–130CrossRef
12.
Zurück zum Zitat Kameyama S, Tanaka R, Kawaguchi T, Honda Y, Yamazaki H, Hasegawa A (1996) Long-term follow-up of the residual intracanalicular tumours after subtotal removal of acoustic neurinomas. Acta Neurochir (Wien) 138(2):206–209CrossRef Kameyama S, Tanaka R, Kawaguchi T, Honda Y, Yamazaki H, Hasegawa A (1996) Long-term follow-up of the residual intracanalicular tumours after subtotal removal of acoustic neurinomas. Acta Neurochir (Wien) 138(2):206–209CrossRef
13.
Zurück zum Zitat Sridhar K, Ramamurthi R, Vasudevan MC, Ramamurthi B (2001) Giant invasive spinal schwannomas: definition and surgical management. J Neurosurg 94(2 Suppl):210–215PubMed Sridhar K, Ramamurthi R, Vasudevan MC, Ramamurthi B (2001) Giant invasive spinal schwannomas: definition and surgical management. J Neurosurg 94(2 Suppl):210–215PubMed
14.
Zurück zum Zitat Park SC, Chung SK, Choe G, Kim HJ (2009) Spinal intraosseous schwannoma: a case report and review. J Korean Neurosurg Soc 46(4):403–408PubMedCrossRef Park SC, Chung SK, Choe G, Kim HJ (2009) Spinal intraosseous schwannoma: a case report and review. J Korean Neurosurg Soc 46(4):403–408PubMedCrossRef
15.
Zurück zum Zitat Shrout PE, Fleiss JL (1979) Intraclass correlations: uses in assessing rater reliability. Psychol Bull 86(2):420–428PubMedCrossRef Shrout PE, Fleiss JL (1979) Intraclass correlations: uses in assessing rater reliability. Psychol Bull 86(2):420–428PubMedCrossRef
16.
Zurück zum Zitat Grayeli AB, Kalamarides M, Ferrary E et al (2005) Conservative management versus surgery for small vestibular schwannomas. Acta Otolaryngol 125(10):1063–1068CrossRef Grayeli AB, Kalamarides M, Ferrary E et al (2005) Conservative management versus surgery for small vestibular schwannomas. Acta Otolaryngol 125(10):1063–1068CrossRef
17.
Zurück zum Zitat Yoshimoto Y (2005) Systematic review of the natural history of vestibular schwannoma. J Neurosurg 103(1):59–63PubMedCrossRef Yoshimoto Y (2005) Systematic review of the natural history of vestibular schwannoma. J Neurosurg 103(1):59–63PubMedCrossRef
18.
Zurück zum Zitat Raut VV, Walsh RM, Bath AP et al (2004) Conservative management of vestibular schwannomas—second review of a prospective longitudinal study. Clin Otolaryngol Allied Sci 29(5):505–514PubMedCrossRef Raut VV, Walsh RM, Bath AP et al (2004) Conservative management of vestibular schwannomas—second review of a prospective longitudinal study. Clin Otolaryngol Allied Sci 29(5):505–514PubMedCrossRef
19.
Zurück zum Zitat Rohit Piccirillo E, Jain Y, Augurio A, Sanna M (2006) Preoperative predictive factors for hearing preservation in vestibular schwannoma surgery. Ann Otol Rhinol Laryngol 115(1):41–46PubMed Rohit Piccirillo E, Jain Y, Augurio A, Sanna M (2006) Preoperative predictive factors for hearing preservation in vestibular schwannoma surgery. Ann Otol Rhinol Laryngol 115(1):41–46PubMed
20.
Zurück zum Zitat Bakkouri WE, Kania RE, Guichard JP, Lot G, Herman P, Huy PT (2009) Conservative management of 386 cases of unilateral vestibular schwannoma: tumor growth and consequences for treatment. J Neurosurg 110(4):662–669PubMedCrossRef Bakkouri WE, Kania RE, Guichard JP, Lot G, Herman P, Huy PT (2009) Conservative management of 386 cases of unilateral vestibular schwannoma: tumor growth and consequences for treatment. J Neurosurg 110(4):662–669PubMedCrossRef
21.
Zurück zum Zitat Bederson JB, von Ammon K, Wichmann WW, Yasargil MG (1991) Conservative treatment of patients with acoustic tumors. Neurosurgery 28(5):646–650; discussion 650–641 Bederson JB, von Ammon K, Wichmann WW, Yasargil MG (1991) Conservative treatment of patients with acoustic tumors. Neurosurgery 28(5):646–650; discussion 650–641
22.
Zurück zum Zitat Stangerup SE, Caye-Thomasen P, Tos M, Thomsen J (2006) The natural history of vestibular schwannoma. Otol Neurotol 27(4):547–552PubMedCrossRef Stangerup SE, Caye-Thomasen P, Tos M, Thomsen J (2006) The natural history of vestibular schwannoma. Otol Neurotol 27(4):547–552PubMedCrossRef
23.
Zurück zum Zitat Gerdes J, Schwab U, Lemke H, Stein H (1983) Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31(1):13–20PubMedCrossRef Gerdes J, Schwab U, Lemke H, Stein H (1983) Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31(1):13–20PubMedCrossRef
24.
Zurück zum Zitat O’Reilly BF, Kishore A, Crowther JA, Smith C (2004) Correlation of growth factor receptor expression with clinical growth in vestibular schwannomas. Otol Neurotol 25(5):791–796PubMedCrossRef O’Reilly BF, Kishore A, Crowther JA, Smith C (2004) Correlation of growth factor receptor expression with clinical growth in vestibular schwannomas. Otol Neurotol 25(5):791–796PubMedCrossRef
25.
Zurück zum Zitat Brown DC, Gatter KC (2002) Ki67 protein: the immaculate deception? Histopathology 40(1):2–11PubMedCrossRef Brown DC, Gatter KC (2002) Ki67 protein: the immaculate deception? Histopathology 40(1):2–11PubMedCrossRef
26.
Zurück zum Zitat Yokoyama M, Matsuda M, Nakasu S, Nakajima M, Handa J (1996) Clinical significance of Ki-67 staining index in acoustic neurinoma. Neurol Med Chir (Tokyo) 36(10):698–702; discussion 702–693 Yokoyama M, Matsuda M, Nakasu S, Nakajima M, Handa J (1996) Clinical significance of Ki-67 staining index in acoustic neurinoma. Neurol Med Chir (Tokyo) 36(10):698–702; discussion 702–693
27.
Zurück zum Zitat Niemczyk K, Vaneecloo FM, Lecomte MH et al (2000) Correlation between Ki-67 index and some clinical aspects of acoustic neuromas (vestibular schwannomas). Otolaryngology-Head Neck Surg 123(6):779–783CrossRef Niemczyk K, Vaneecloo FM, Lecomte MH et al (2000) Correlation between Ki-67 index and some clinical aspects of acoustic neuromas (vestibular schwannomas). Otolaryngology-Head Neck Surg 123(6):779–783CrossRef
28.
Zurück zum Zitat Aguiar PH, Tatagiba M, Samii M, Dankoweittimpe E, Ostertag H (1995) The comparison between the growth fraction of bilateral vestibular schwannomas in neurofibromatosis-2 (NF2) and unilateral vestibular schwannomas using the monoclonal-antibody MIB 1. Acta Neurochir (Wien) 134(1–2):40–45CrossRef Aguiar PH, Tatagiba M, Samii M, Dankoweittimpe E, Ostertag H (1995) The comparison between the growth fraction of bilateral vestibular schwannomas in neurofibromatosis-2 (NF2) and unilateral vestibular schwannomas using the monoclonal-antibody MIB 1. Acta Neurochir (Wien) 134(1–2):40–45CrossRef
29.
Zurück zum Zitat Saito K, Kato M, Susaki N, Nagatani T, Nagasaka T, Yoshida J (2003) Expression of Ki-67 antigen and vascular endothelial growth factor in sporadic and neurofibromatosis type 2-associated schwannomas. Clin Neuropathol 22(1):30–34PubMed Saito K, Kato M, Susaki N, Nagatani T, Nagasaka T, Yoshida J (2003) Expression of Ki-67 antigen and vascular endothelial growth factor in sporadic and neurofibromatosis type 2-associated schwannomas. Clin Neuropathol 22(1):30–34PubMed
30.
Zurück zum Zitat Antinheimo J, Haapasalo H, Seppala M, Sainio M, Carpen O, Jaaskelainen J (1995) Proliferative potential of sporadic and neurofibromatosis 2-associated schwannomas as studied by MIB-1 (Ki-67) and PCNA labeling. J Neuropathol Exp Neurol 54(6):776–782PubMedCrossRef Antinheimo J, Haapasalo H, Seppala M, Sainio M, Carpen O, Jaaskelainen J (1995) Proliferative potential of sporadic and neurofibromatosis 2-associated schwannomas as studied by MIB-1 (Ki-67) and PCNA labeling. J Neuropathol Exp Neurol 54(6):776–782PubMedCrossRef
31.
Zurück zum Zitat Nakamura M, Iwanami A, Tsuji O et al (2013) Long-term surgical outcomes of cervical dumbbell neurinomas. J Orthop Sci 18(1):8–13PubMedCrossRef Nakamura M, Iwanami A, Tsuji O et al (2013) Long-term surgical outcomes of cervical dumbbell neurinomas. J Orthop Sci 18(1):8–13PubMedCrossRef
32.
Zurück zum Zitat Kufeld M, Wowra B, Muacevic A, Zausinger S, Tonn JC (2012) Radiosurgery of spinal meningiomas and schwannomas. Technol Cancer Res Treat 11(1):27–34PubMed Kufeld M, Wowra B, Muacevic A, Zausinger S, Tonn JC (2012) Radiosurgery of spinal meningiomas and schwannomas. Technol Cancer Res Treat 11(1):27–34PubMed
33.
Zurück zum Zitat Gerszten PC, Chen S, Quader M, Xu YG, Novotny J, Flickinger JC (2012) Radiosurgery for benign tumors of the spine using the Synergy S with cone-beam computed tomography image guidance. J Neurosurg 117:197–202PubMedCrossRef Gerszten PC, Chen S, Quader M, Xu YG, Novotny J, Flickinger JC (2012) Radiosurgery for benign tumors of the spine using the Synergy S with cone-beam computed tomography image guidance. J Neurosurg 117:197–202PubMedCrossRef
34.
Zurück zum Zitat Fawcett KJ, Dahlin DC (1967) Neurilemmoma of bone. Am J Clin Pathol 47(6):759–766PubMed Fawcett KJ, Dahlin DC (1967) Neurilemmoma of bone. Am J Clin Pathol 47(6):759–766PubMed
Metadaten
Titel
The fate of spinal schwannomas following subtotal resection: a retrospective multicenter study by the Korea spinal oncology research group
verfasst von
Seil Sohn
Chun Kee Chung
Sung-Hye Park
Eun-Sang Kim
Ki-Jeong Kim
Chi Heon Kim
Publikationsdatum
01.09.2013
Verlag
Springer US
Erschienen in
Journal of Neuro-Oncology / Ausgabe 3/2013
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-013-1190-7

Weitere Artikel der Ausgabe 3/2013

Journal of Neuro-Oncology 3/2013 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

„Restriktion auf vier Wochen Therapie bei Schlaflosigkeit ist absurd!“

06.05.2024 Insomnie Nachrichten

Chronische Insomnie als eigenständiges Krankheitsbild ernst nehmen und adäquat nach dem aktuellen Forschungsstand behandeln: Das forderte der Schlafmediziner Dr. Dieter Kunz von der Berliner Charité beim Praxis Update.

Stuhltransfusion könnte Fortschreiten von Parkinson-Symptomen bremsen

03.05.2024 Parkinson-Krankheit Nachrichten

Kann eine frühzeitige Stuhltransplantation das Fortschreiten von Parkinson-Symptomen verlangsamen? Die Ergebnisse einer randomisierten Phase-2-Studie scheinen dafür zu sprechen.

Frühe Tranexamsäure-Therapie nützt wenig bei Hirnblutungen

02.05.2024 Hirnblutung Nachrichten

Erhalten Personen mit einer spontanen Hirnblutung innerhalb von zwei Stunden nach Symptombeginn eine Tranexamsäure-Therapie, kann dies weder die Hämatomexpansion eindämmen noch die Mortalität senken.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.